A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches
NCT04211454 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Conditions
Interventions
- OTHER
-
No intervention
There is no intervention for this study.
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
A Nutritional Intervention for Migraines-2
NCT01699009 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Effectiveness of a Headache Management Program in Primary Care Settings
NCT05067725 ·Status: COMPLETED ·Phase: NA
-
Probiotics for the Prophylaxis of Migraine
NCT04305522 ·Status: UNKNOWN ·Phase: NA
-
Study of Intravenous Erenumab in Patients With Status Migrainosus
NCT04920331 ·Status: WITHDRAWN ·Phase: PHASE1
-
A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM
NCT06167655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines
NCT01749423 ·Status: WITHDRAWN
-
KETOMIGRAINE: Ketogenic Diet in Drug-resistant Chronic Migraineurs
NCT05313503 ·Status: UNKNOWN ·Phase: NA
-
A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist
NCT04294147 ·Status: COMPLETED ·Phase: PHASE4
-
A Nutritional Intervention for Migraines
NCT01547494 ·Status: COMPLETED ·Phase: NA
-
Real World Effectiveness of Eptinezumab in Participants With Migraine
NCT05284019 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of LY2951742 in Participants With Migraine
NCT01625988 ·Status: COMPLETED ·Phase: PHASE2
-
Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
NCT04271202 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache
NCT02163993 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
NCT02174861 ·Status: COMPLETED ·Phase: PHASE2
-
A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
NCT01946126 ·Status: COMPLETED
-
A Study in Migraine Prevention
NCT01184508 ·Status: TERMINATED ·Phase: PHASE2
-
Neurostimulation Device for Treatment of Migraine Headache
NCT01630044 ·Status: COMPLETED ·Phase: NA
-
Comparison of a Drug and Placebo in the Prevention of Migraine Headaches
NCT01122381 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Neurophysiology of Prophylactic Treatment in Migraine
NCT04019496 ·Status: COMPLETED
-
The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine
NCT04064879 ·Status: SUSPENDED ·Phase: NA
-
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine
NCT02959190 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Clinical Follow-up for Long-term Use of Intranasal Kinetic Oscillation in Subjects With Chronic Migraine
NCT05843721 ·Status: TERMINATED ·Phase: NA
-
Exploring Clinical Trial Experiences of Patients With Migraine
NCT05675189 ·Status: NOT_YET_RECRUITING
-
Study in Participants With Acute Migraines Headaches
NCT00804973 ·Status: TERMINATED ·Phase: PHASE2
-
Biomarker Study in Participants With Migraine
NCT02766517 ·Status: COMPLETED ·Phase: EARLY_PHASE1